影响Rhipicephalus microplus对酸盐耐药性的选择因素
Roger I Rodriguez-Vivas1, Gabriela Janett Flota-Burgos1, Marco Torres-Castro2
1Departamento de Salud Animal y Medicina Preventiva, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Yucatán, Mérida, Yucatán, Mexico.
Veterinary parasitology
|February 18, 2026
概括
经常使用虫杀虫剂导致Rhipicephalus microplus的耐药性,影响全球的牛. 了解影响耐药性的因素是可持续控制策略的关键.
科学领域:
- 兽医昆虫学 兽医昆虫学
- 寄生虫学的寄生虫学
- 分子生物学分子生物学
背景情况:
- Rhipicephalus microplus 是一种主要的牛外寄生虫,在全球范围内造成重大经济损失.
- 杀剂用于控制导致虫种群中普遍存在的耐药性.
- 导致R. microplus对酸盐耐药性的因素是复杂的和多因素的.
研究的目的:
- 综合审查和总结影响Rhipicephalus microplus.acaricide耐药性选择的因素.
- 为了阐明抗虫药物耐药的的遗传选择过程.
- 为可持续控制R. microplus.提出缓解策略.
主要方法:
- 文献综述和现有关于R. microplus. 抗素耐药性的研究的综合.
- 对包括杀虫剂使用模式,生物学,遗传学和环境影响在内的因素的分析.
- 讨论驱动抗性的遗传选择机制.
主要成果:
- 高频率的粉剂应用,特别是具有相同作用模式的粉剂,是抗性的主要驱动因素.
- 生物学,遗传学,杀虫剂特性,农场管理和环境因素也对抗性选择作出了重大贡献.
- 遗传选择过程有利于耐药个体的生存和繁殖.
结论:
- 可持续控制R. microplus需要综合战略,以解决驱动抗素耐药性的多方面的因素.
- 缓解措施的重点应该是减少杀虫剂使用的频率,并实施多种控制方法.
- 了解耐药性的遗传基础对于开发有效和长期的管理计划至关重要.
相关概念视频
00:57Antibiotic Selection
Overview
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...